Debating healthy obesity, delaying type 1 diabetes, and visiting bone rooms
First this week, Staff Writer Jennifer Couzin-Frankel joins host Sarah Crespi to discuss the paradox of metabolically healthy obesity. They chat about the latest research into the relationships between markers of metabolic health—such as glucose or cholesterol levels in the blood—and obesity. They aren’t as tied as you might think.
Next, Colin Dayan, professor of clinical diabetes and metabolism at Cardiff University and senior clinical researcher at the Wellcome Centre for Human Genetics at the University of Oxford, joins Sarah to discuss his contribution to a special issue on type 1 diabetes. In his re...
Source: Science Magazine Podcast - July 29, 2021 Category: Science Authors: Science Magazine Source Type: podcasts
Debating healthy obesity, delaying type 1 diabetes, and visiting bone rooms
First this week, Staff Writer Jennifer Couzin-Frankel joins host Sarah Crespi to discuss the paradox of metabolically healthy obesity. They chat about the latest research into the relationships between markers of metabolic health—such as glucose or cholesterol levels in the blood—and obesity. They aren’t as tied as you might think.
Next, Colin Dayan, professor of clinical diabetes and metabolism at Cardiff University and senior clinical researcher at the Wellcome Centre for Human Genetics at the University of Oxford, joins Sarah to discuss his contribution to a special issue on type 1 diabetes. In his review, Colin ...
Source: Science Magazine Podcast - July 29, 2021 Category: Science Authors: Science Magazine Source Type: podcasts
Debating healthy obesity, delaying type 1 diabetes, and visiting bone rooms
First this week, Staff Writer Jennifer Couzin-Frankel joins host Sarah Crespi to discuss the paradox of metabolically healthy obesity. They chat about the latest research into the relationships between markers of metabolic health —such as glucose or cholesterol levels in the blood—and obesity. They aren’t as tied as you might think.
Next, Colin Dayan, professor of clinical diabetes and metabolism at Cardiff University and senior clinical researcher at the Wellcome Centre for Human Genetics at the University of Oxford, joins Sarah to discuss his contribution to a special issue on type 1 diabetes. In his review, Colin...
Source: Science Magazine Podcast - July 26, 2021 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins
Listen to an audio podcast of the July 20, 2021 FDA Drug Safety Communication, FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 22, 2021 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Diabetes Core Update – December 2020
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - November 24, 2020 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Statins for primary prevention - How good is the evidence
Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease.
Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals,... (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 21, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Statins for primary prevention - How good is the evidence
Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease.
Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals, and what needs to be done to finally answer the questions about efficacy and harms.
Read the full analysis:https://www.bmj.com/content/367/bmj.l5674 (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 21, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Statins for primary prevention - How good is the evidence
Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease.
Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals, and what needs to be done to finally answer the questions about efficacy and harms.
Read the full analysis:
https://www.bmj.com/content/367/bmj.l5674 (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 21, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
JAMA Cardiology : Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels
Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 25, 2019 Category: General Medicine Source Type: podcasts
TWiV 566: Chicken gumbo and a corona
The TWiV team reveals the protein corona that surrounds virus particles and influences infectivity and amyloid aggregation, and a proofreading-impaired herpesvirus that produces quasispecies-like populations. Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Guest: Kiki Warren Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Human fetal tissue research restrictions (The Scientist) Viral protein corona (Nat Commun) Proofreading-impaired herpesvirus (Nat Micro) Phage quasispecies (Cell) Letters read on TWiV 566 Timestamps by Jolene. Thanks! Weekly Science Picks...
Source: This Week in Virology - MP3 Edition - September 22, 2019 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
JAMA Neurology : Association Between Statin Use and Risk of Dementia After a Concussion
Interview with Donald A. Redelmeier, MD, FRCPC, MSHSR, FACP, author of Association Between Statin Use and Risk of Dementia After a Concussion (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 20, 2019 Category: General Medicine Source Type: podcasts
Talk Evidence - Shoulders, statins and doctors messes
Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.
They start by talking about shoulders - what does the evidence say about treating subacromial pain, and why the potential for a subgroup effect shouldn't change our views about stop surgery (for now, more research needed).
(16.00) Statins - more uncertainty about statins, this is now looking at o lder people. Age is a big risk factor for cardiovascular disease - at what point does that risk overwhelm any potential benefit from taking statins?
(20.30)Carl explains his rule-of-thumb for turning relative ris...
Source: The BMJ Podcast - March 28, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - Shoulders, statins and doctors messes
Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.
They start by talking about shoulders - what does the evidence say about treating subacromial pain, and why the potential for a subgroup effect shouldn't change our views about stop surgery (for now, more research needed).
(16.00)... (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 28, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - Shoulders, statins and doctors messes
Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month.
They start by talking about shoulders - what does the evidence say about treating subacromial pain, and why the potential for a subgroup effect shouldn't change our views about stop surgery (for now, more research needed).
(16.00) Statins - more uncertainty about statins, this is now looking at older people. Age is a big risk factor for cardiovascular disease - at what point does that risk overwhelm any potential benefit from taking statins?
(20.30)Carl explains his rule-of-thumb for turning relative risks...
Source: The BMJ Podcast - March 28, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
